Nkarta, Inc. Common Stock (NKTX) Stock
NASDAQ · NKTX
2.88
Fundamentals
Market cap
$202.70M
Price / Earnings ratio
-1.7x
Price / Sales ratio
N/A
Price / Book ratio
0.8x
Return on assets
-0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Nkarta, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees106
CEOMr. Paul J. Hastings
IPO DateJul 10, 2020
HeadquartersSouth San Francisco, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul J. Hastings | CEO & Director | 1960 |
| Dr. Nadir Mahmood Ph.D. | President and Principal Accounting & Financial Officer | 1980 |
| Dr. Shawn Rose M.D., Ph.D. | Chief Medical Officer and Head of Research & Development | — |
Fundamentals
Valuation
Market cap$202.70M
Price-to-sales ratioN/A
Price-to-book value0.82
Price-earnings ratio-1.70
Return on Equity-31.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.57
Income Statement
Average volume599,933
EBITDA$-88.69M
1 year high (52w)$3.72
1 year low (52w)$1.70
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



